Physician

Alexey A Ryskin, M.D.

According to 2025 Medicare claims, Alexey Ryskin, M.D. (NPI: 1366457236) practices interventional pain management (ipm) in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is SEATTLE PAIN RELIEF PLLC (NPI: 1710240841; TIN: 45-5527273) and primary practice location at 98003-8365.

Ryskin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 405 traditional Medicare patients, billed 21,769 HCPCS/CPT codes, and received $1,983,307 in Medicare payments. The top billing code was G0483 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 1,294 prescription claims across 492 beneficiaries totaling $66,379 in drug costs, led by Oxycontin (Oxycodone Hcl). 2020 DME data shows 278 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $341,940 to $1,983,307. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $96,066 to $66,379. For DME billing, this smaller-volume category changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	250	4,388	$341,940
2016	452	10,808	$640,445
2017	628	10,555	$830,436
2018	707	18,934	$1,661,055
2019	703	25,531	$2,271,317
2020	642	25,954	$2,245,204
2021	599	18,433	$2,022,472
2022	530	17,800	$1,848,962
2023	481	25,008	$2,293,711
2024	405	21,769	$1,983,307

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	224	1,188	$96,066
2016	335	1,078	$81,519
2017	383	1,057	$89,872
2018	416	951	$83,438
2019	294	666	$58,956
2020	241	508	$36,297
2021	188	455	$25,342
2022	254	603	$32,823
2023	438	915	$61,074
2024	492	1,294	$66,379

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	67	67	$55,282
2016	99	99	$80,975
2017	90	90	$74,090
2018	67	67	$55,171
2019	283	331	$179,306
2020	247	278	$117,672
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	334	2,736	$239
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	365	3,106	$96
96132	Evaluation of neuropsychological test, first hour	311	2,778	$95
96130	Evaluation of psychological test, first hour	311	2,770	$90
80307	Testing for presence of drug, by chemistry analyzers	342	2,820	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	21	458	$11,059
Buprenorphine	Buprenorphine	27	756	$5,890
Xtampza Er	Oxycodone Myristate	12	330	$5,431
Oxycodone Hcl	Oxycodone Hcl	273	6,479	$5,016
Naloxone Hcl	Naloxone Hcl	71	620	$4,788

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Alexey A. Ryskin, M.D.?

Tedicare shows public-source Medicare data for Alexey A. Ryskin, M.D. (NPI 1366457236), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexey A. Ryskin, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexey A. Ryskin, M.D.?

Alexey A. Ryskin, M.D. is linked to SEATTLE PAIN RELIEF PLLC (billing NPI 1710240841) in the available physician profile data.

Does Alexey A. Ryskin, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.